Jun-Jie Hou
Overview
Explore the profile of Jun-Jie Hou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hou J, Ding L, Yang T, Yang Y, Jin Y, Zhang X, et al.
Microb Pathog
. 2024 Jan;
188:106560.
PMID: 38272327
Inflammatory bowel disease (IBD) is a chronic, recurrent inflammatory disease caused by the destruction of the intestinal mucosal epithelium that affects a growing number of people worldwide. Although the etiology...
2.
Hou J, Li W, Wang X, Ma A, Qin Y
Front Pharmacol
. 2023 Nov;
14:1260134.
PMID: 37954844
Extracellular vesicles (EVs) mediate inflammation, immune responses, gut barrier integrity, and intestinal homeostasis. Recently, the application of EVs in the treatment of inflammatory bowel disease (IBD) has been under intensive...
3.
Hou J, Ma A, Qin Y
Front Cell Infect Microbiol
. 2023 Nov;
13:1279172.
PMID: 37942478
Inflammatory bowel disease (IBD) is a chronic inflammatory intestinal disease that affects more than 3.5 million people, with rising prevalence. It deeply affects patients' daily life, increasing the burden on...
4.
Hou J, Tian H, Lu B
Comput Intell Neurosci
. 2022 Oct;
2022:5508365.
PMID: 36210996
This paper analyzes the quantitative assessment model of the swimming training effect based on the deep neural network by constructing a deep neural network model and designing a quantitative assessment...
5.
Chen Y, Li Y, Wang X, Wang Z, Hou J, Su S, et al.
World J Gastroenterol
. 2022 Mar;
28(5):532-546.
PMID: 35316963
Background: (), (), and () are probiotics that are widely used in the clinical treatment of irritable bowel syndrome (IBS). Whether the supernatants of these three probiotics can improve gastrointestinal...
6.
Hou J, Wang X, Wang Y, Wang B
Crit Rev Microbiol
. 2021 Dec;
48(6):696-713.
PMID: 34936854
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disease that disturbs the physiology and psychology of patients and increases the burden on families, the healthcare system, society, and economic...
7.
Han X, Fang Y, Liu S, Tan Y, Hou J, Zhao L, et al.
Medicine (Baltimore)
. 2021 Aug;
100(30):e26701.
PMID: 34397698
Background: Advanced cancer (AC) patients experience serious physical and psychological problems with the disease progression. When approaching the end of life, these patients have to cope with not only the...
8.
Hou J, Wang X, Li Y, Su S, Wang Y, Wang B
Microb Pathog
. 2021 May;
157:104995.
PMID: 34048892
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disease that affects 3.8-9.2% of the world population. It affects the physiology and psychology of patients and increases the burden on...
9.
Chen X, Wang J, Yang X, Qi J, Hou J
J Food Sci
. 2016 Jul;
81(9):C2149-57.
PMID: 27467966
Rutin is a common dietary flavonoid with important antioxidant and pharmacological activities. However, its application in the food industry is limited mainly because of its poor water solubility. The subcritical...
10.
Chen X, Fu S, Hou J, Guo J, Wang J, Yang X
Food Chem
. 2016 Jun;
211:836-44.
PMID: 27283703
Structuring edible oils into solid lipids without saturated and trans fats has attracted increasing interest due to the benefits for human health and promises potential as novel delivery systems for...